![]() |
市场调查报告书
商品编码
1960009
硅胶泡棉敷料市场-全球产业规模、份额、趋势、机会、预测:按产品类型、应用、最终用户、地区和竞争对手划分,2021-2031年Silicone Foam Dressings Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type, By Application, By End User, By Region & Competition, 2021-2031F |
||||||
全球硅胶泡棉敷料市场预计将从 2025 年的 15.8 亿美元成长到 2031 年的 21.1 亿美元,复合年增长率为 4.94%。
这些可吸收的多层医疗设备采用柔软的硅胶接触层来管理伤口渗出液,同时最大限度地减少移除过程中的疼痛和组织损伤。推动这一市场成长的主要因素是慢性伤口(例如糖尿病足溃疡和压疮)在全球范围内的日益普遍。这些伤口需要有效的长期照护方案,而人口老化导致皮肤脆弱、癒合延迟,进一步加剧了这项需求。正如国际糖尿病联盟(IDF)在2024年指出的那样,全球约有5.89亿成年人患有糖尿病,凸显了开发先进的伤口管理产品以应对相关併发症的迫切需求。
| 市场概览 | |
|---|---|
| 预测期 | 2027-2031 |
| 市场规模:2025年 | 15.8亿美元 |
| 市场规模:2031年 | 21.1亿美元 |
| 复合年增长率:2026-2031年 | 4.94% |
| 成长最快的细分市场 | 慢性伤口 |
| 最大的市场 | 北美洲 |
儘管这些特殊敷料具有明显的临床优势,但与传统纱布产品相比,其高昂的价格已成为市场推广的一大障碍。这种价格差异限制了其广泛应用,尤其是在医疗预算有限的发展中地区,这些地区往往优先考虑采购量而非先进技术。此外,国际上缺乏统一的报销政策也阻碍了将硅胶泡棉敷料纳入标准治疗通讯协定。因此,许多医疗机构被迫依赖价格更低、疗效较差的替代方案,限制了先进硅胶泡沫疗法的广泛应用。
慢性伤口,尤其是糖尿病足溃疡的发生率不断上升,是全球硅胶泡棉敷料市场的主要驱动力。随着糖尿病患者数量的增加,对能够有效控制大量渗出液并防止浸渍的敷料的需求日益增长,而硅胶泡棉敷料因其能够维持湿润环境而备受青睐。近期产业趋势也印证了这项强劲的临床需求。例如,科乐普公司在2024年11月报告称,其先进创伤护理业务在2023/24财年实现了10%的内部成长,主要得益于慢性病护理领域的强劲发展势头。这一增长表明,慢性皮肤病负担的加重与市场商业性扩张之间存在直接关联。
同时,全球外科手术数量的不断增长推动了相关技术的应用,尤其是在术后切口管理方面,旨在降低感染风险并最大限度地减少疤痕。这一趋势正促使人们从传统的纱布转向非侵入性的硅胶泡沫解决方案。美国癌症协会 (ACS) 的统计数据也印证了外科手术量与创伤护理需求之间的相关性。该协会在 2024 年 1 月预测,美国新增癌症病例将超过 200 万例,这将导致手术需求的大幅增加。为了满足这项需求,Molnlycke 公司于 2024 年 3 月宣布,其 2023 财年的年度净销售额达到创纪录的 19.24 亿欧元。这一业绩归功于其专注于外科手术和创伤护理解决方案的策略策略。
硅胶泡棉敷料的高昂购置成本构成了市场扩张的重大经济障碍,尤其是在医疗基础设施成本敏感的地区。儘管这些先进敷料在治疗慢性伤口方面具有卓越的临床疗效,但与传统纱布相比,其高昂的价格迫使采购部门优先考虑即时预算削减,而非长期疗效。此外,健保报销政策的不一致也加剧了这种财务压力,因为这些政策往往无法涵盖先进创伤护理产品的高昂成本。因此,医疗机构常常被迫使用疗效较差但成本更低的替代品,这实际上抑制了资金紧张的发展中市场和成熟市场的收入成长。
这些预算限制在医疗资金分配给医疗设备体现得淋漓尽致。根据欧洲医疗技术协会(MedTech Europe)2024年的数据,包括耗材创伤护理设备在内的医疗技术支出约占欧洲医疗总支出的7.9%。这种有限的分配凸显了特种硅胶敷料在资金竞争方面面临的严峻挑战。儘管慢性伤口数量的增加带来了明显的临床需求,但这些资金限制阻碍了先进的硅胶解决方案在标准治疗通讯协定中取代价格较低的传统产品。
市场正经历着一场根本性的转变,即从被动治疗转向主动降低风险,从而将硅胶泡棉敷料用于预防压疮。医疗机构正越来越多地将符合人体解剖结构的硅胶泡棉敷料纳入高风险手术和重症监护患者的标准通讯协定中,以重新分配压力并减少剪切力。这种临床转变正成为製造商重要的收入来源。例如,史密斯医疗(Smith & Nephew)在2024年2月发布的报告显示,其高阶伤口管理部门2023年的核心收入成长了6.4%,反映出市场对感染控制和压力管理产品线的持续需求。这一趋势表明,预防性技术在急诊环境中的价值日益凸显。
同时,居家照护模式的普及速度显着加快,对适用于非临床环境的伤口管理解决方案的需求也随之增长。随着医疗系统致力于降低再入院率和医疗成本,对于居家治疗慢性溃疡的患者而言,能够延长佩戴时间且易于使用的硅胶泡棉敷料的需求日益增长。这种向分散式护理模式的转变正在推动该领域的内部成长。 2024年3月,康维特集团宣布,其高级创伤护理部门2023年的自然销售额增长了9.5%,并将这一业绩归功于慢性病护理解决方案的强劲需求。这一成长轨迹凸显了便捷易用的医疗设备在支持全球转变为以社区为中心的医疗服务模式过程中所扮演的重要角色。
The Global Silicone Foam Dressings Market is projected to expand from USD 1.58 Billion in 2025 to USD 2.11 Billion by 2031, registering a CAGR of 4.94%. These absorbent, multi-layered medical devices utilize a soft silicone contact layer to manage wound exudate while minimizing pain and tissue trauma during removal. A primary factor fueling this growth is the increasing global prevalence of chronic wounds, such as diabetic foot ulcers and pressure injuries, which demand effective long-term care solutions. This need is further intensified by an aging global population that is prone to skin fragility and slower healing. As noted by the International Diabetes Federation in 2024, nearly 589 million adults globally were living with diabetes, highlighting the urgent necessity for advanced wound management products to address associated complications.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 1.58 Billion |
| Market Size 2031 | USD 2.11 Billion |
| CAGR 2026-2031 | 4.94% |
| Fastest Growing Segment | Chronic Wounds |
| Largest Market | North America |
Despite the clear clinical advantages, the market encounters significant obstacles due to the high acquisition costs of these specialized dressings compared to traditional gauze options. This price disparity restricts widespread adoption, particularly in developing regions with limited healthcare budgets where procurement often prioritizes volume over advanced technology. Additionally, inconsistent reimbursement policies across various international territories create financial hurdles that impede the integration of silicone foam solutions into standard treatment protocols. Consequently, many healthcare providers are forced to rely on less expensive and less effective alternatives, limiting the potential reach of advanced silicone foam therapies.
Market Driver
The escalating prevalence of chronic wounds, particularly diabetic foot ulcers, acts as the primary catalyst driving the global silicone foam dressings market. As the diabetic population grows, there is an intensified need for dressings that can manage high levels of exudate while preventing maceration, with silicone foam being preferred for its ability to maintain a moist healing environment. This strong clinical demand is evident in recent industry performance; for instance, Coloplast reported in November 2024 that their Advanced Wound Care business achieved 10% organic growth for the 2023/24 financial year, a rise largely fueled by momentum in the chronic care sector. This growth illustrates the direct link between the rising burden of chronic skin conditions and the commercial expansion of the market.
Simultaneously, the increasing volume of surgical procedures worldwide is boosting adoption, specifically for postoperative incision management aimed at reducing infection risks and minimizing scarring. This trend is driving a shift from traditional gauze to atraumatic silicone foam solutions. The correlation between surgical activity and wound care demand is supported by statistics from the American Cancer Society, which projected in January 2024 that new cancer cases in the US would exceed 2 million, necessitating a higher number of surgeries. Reflecting this demand, Molnlycke announced in March 2024 that it achieved record annual net sales of EUR 1,924 million in 2023, a performance attributed to its strategic focus on surgical and wound care solutions.
Market Challenge
The substantial acquisition cost of silicone foam dressings presents a significant economic barrier that hinders market expansion, especially in regions with cost-sensitive healthcare infrastructures. Although these advanced dressings provide superior clinical outcomes for chronic wounds, their premium pricing compared to traditional gauze often compels procurement departments to favor immediate budget savings over long-term efficacy. This financial pressure is compounded by inconsistent reimbursement policies that frequently fail to cover the higher costs of advanced wound care products. As a result, healthcare providers are often left with little choice but to utilize less effective, lower-cost alternatives, effectively capping revenue growth in both developing and established markets facing fiscal constraints.
This budgetary strain is clearly reflected in the allocation of healthcare funds for medical devices. According to MedTech Europe data from 2024, expenditure on medical technologies-including consumable wound care devices-averaged approximately 7.9% of total healthcare spending across European systems. This restrictive allocation emphasizes the intense competition for financial resources that specialized silicone dressings face. Despite the clear clinical necessity driven by the rising prevalence of chronic wounds, these financial limitations hamper the ability of advanced silicone solutions to displace cheaper traditional options within standard care protocols.
Market Trends
The market is witnessing a fundamental shift toward the prophylactic use of silicone foam dressings for pressure injury prevention, moving the focus from reactive treatment to proactive risk mitigation. Healthcare institutions are increasingly incorporating anatomically contoured silicone foams into standard protocols for at-risk surgical and ICU patients to redistribute pressure and reduce shear forces. This clinical pivot is becoming a vital revenue source for manufacturers. For example, Smith+Nephew reported in February 2024 that their Advanced Wound Management unit delivered 6.4% underlying revenue growth in 2023, reflecting sustained demand for infection control and pressure management portfolios. This trend highlights the growing value placed on preventative technologies in acute care settings.
Concurrently, there is a distinct acceleration in the adoption of home-based care models, which drives the need for wound management solutions suitable for non-clinical environments. As healthcare systems seek to lower hospital readmissions and costs, there is rising demand for silicone foam dressings that offer extended wear times and ease of application for patients managing chronic ulcers at home. This move toward decentralized treatment is fueling organic expansion in the sector. Convatec Group Plc noted in March 2024 that their Advanced Wound Care category achieved 9.5% organic revenue growth in 2023, a performance attributed to the strong adoption of their chronic care solutions. This trajectory underscores the critical role of user-friendly devices in supporting the global shift toward community-centered health delivery.
Report Scope
In this report, the Global Silicone Foam Dressings Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Silicone Foam Dressings Market.
Global Silicone Foam Dressings Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: